<qa>  What is the STUDY of PAZOPANIB AND DOXIL IN PATISTUDY OF PAZOPANIB AND DOXIL IN PATIENTS WITH ADVANCED RELAPSED PLATINUM-SENSITIVE OR PLATINUM-RESISTANT OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL ADENOCARCINOMA: 